Article
Alphavirus replicon vaccines
21 Mar 2012
Abstract excerpt
The alphavirus replicon technology has been utilized for many years to develop vaccines for both veterinary and human applications. Many developments have been made to the replicon platform recently, resulting in improved safety and efficacy of replicon particle (RP) vaccines. This review provides a broad overview of the replicon technology and safety features of the system and discusses the current literature on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
